Abstract
Neuroendocrine differentiation in breast carcinomas has been a matter of discussion since it was first described almost 60 years ago. Indeed, so-called neuroendocrine neoplasms of the breast (Br-NENs) are a less well-defined group of neoplasms than analogous entities in other anatomic sites, such as the lung and the gastroenteropancreatic (GEP) tract. Pure neuroendocrine phenotype is extremely rare, whereas the expression of neuroendocrine markers in usual breast carcinomas, both of special and of non-special type, without evident neuroendocrine morphology, is more common. In this context, the diagnostic criteria and the classification scheme for Br-NENs have been continuously changing over time and real consensus on this topic is still lacking, despite the recent publication of the 5th edition of the WHO classification of breast tumors. In this review, we will recapitulate the evolution of the concept of Br-NEN; revise the available knowledge on their morphological, molecular, and clinical features; and critically discuss the current classification scheme.
Similar content being viewed by others
References
Lloyd RV, Osamura RY, Klöppel G, Rosai J (eds) (2017) WHO classification of tumours of endocrine organs, 4th edition. IARC Press, Lyon
Klimstra DS, Klöppel G, La Rosa S, Rindi G (2019) Classification of neuroendocrine neoplasms of the digestives system. In: Carneiro F, Chan JKC, Cheung NYA, et al (eds) WHO classification of the digestive system tumours, 5th edition. IARC Press, Lyon, pp 16-19
Rindi G, Klimstra DS, Abedi-Ardekani B, et al (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31:1770-1786
Feyrter F, Hartmann G (1963) Uber die carcinoide Wuchsform der Carcinoma mammae, insbesondere das Carcinoma Solidum (gelatinosum) mammae. Frankf Z Pathol 73:24–39
Cubilia AL, Woodruff JM (1977) Primary carcinoid tumors of the breast: a report of 8 cases. Am J Surg Pathol 1:283–292
Capella C, Eusebi V, Mann B, Azzopardi JG (1980) Endocrine differentiation in mucoid carcinoma of the breast. Histopathology 4:613-630
Ferguson DJP, Anderson TJ (1985) Distribution of dense core granules in normal, benign and malignant breast tissue. J Pathol 147:59-65
Nesland JM, Memoli VA, Holm R, Gould VE, Johannessen JV (1985) Breast carcinoma with neuroendocrine differentiation. Ultrastruct Pathol 8:225-240
Capella C, Usellini L, Papotti M, Macri L, Finzi G, Eusebi V, Bussolati G (1990) Ultrastructural features of neuroendocrine differentiated carcinomas of the breast. Ultrastruct Pathol 14:321-334
Bussolati G, Gugliotta P, Sapino A, Eusebi V, Lloyd RV (1985) Chromogranin reactive endocrine cells in argyrophilic carcinomas (“carcinoids”) and normal tissue of the breast. Am J Pathol 120:186–192
Nesland JM, Holm R, Johannessen JV (1986) Breast carcinomas with neuroendocrine activity. In: Hollmann K.H., Verley J.M. (eds) New frontiers in mammary pathology 1986. Developments in Oncology, vol 49. Springer, Dordrecht, pp 187-196
La Rosa S, Usellini L, Riva C, Capella C (2007) Well-differentiated neurotensin-producing neuroendocrine carcinoma of the breast. Report of a case. Histopathology 51:846-847
Papotti M, Macri L, Finzi G, Capella C, Eusebi V, Bussolati G (1989) Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases. Semin Diagn Pathol 61:174-188
Maluf HM, Koerner FC (1994) Carcinomas of the breast with endocrine differentiation: a review. Virchows Arch 425:449-457
Ellis P, Schnitt SJ, Sastre-Garau X, et al (2003) Invasive breast carcinoma In: Tavassoli FA, Devilee P (eds) Tumours of the breast and female genital organs: pathology and genetics. IARC Press, Lyon, pp 13-59
Uccella S, Sessa F, La Rosa S (2015) Diagnostic approach to neuroendocrine neoplasms of the gastrointestinal tract and pancreas. Turk Patoloji Derg 31(Suppl 1):113-127
Bussolati G, Badve S (2012) Carcinomas with neuroendocrine features. In: Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (eds) WHO classification of tumours of the breast. IARC Press, Lyon, pp 62-63
Rosen LE, Gattuso P. Neuroendocrine tumors of the breast (2017) Arch Pathol Lab Med 141:1577-1581.
Rakha EA, Reis-Filho JS, Sasano H, Wu Y (2019) Neuroendocrine neoplasms: introduction. In: WHO classification of tumours editorial board. Breast tumours. WHO classification of tumours series, 5th ed. IARC, Lyon, pp 155
Rakha EA, Reis-Filho JS, Wu Y (2019) Neuroendocrine carcinoma. In: WHO classification of tumours editorial board. Breast tumours. WHO classification of tumours series, 5th ed. IARC, Lyon, pp 159-161
McCullar B, Pandey M, Yaghmour G, Hare F, Patel K, Stein K, Feldman R, Chandler JC, Martin MG (2016) Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung. Breast Cancer Res Treat 158:195-202
Hare F, Giri S, Patel JK, Hahn A, Martin MG (2015) A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy. Springerplus 4:138
Shin SJ, DeLellis RA, Ying L, Rosen PP (2000) Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol 24:1231-1238
Mirza IA, Shahab N (2007) Small cell carcinoma of the breast. Semin Oncol 34:64-66
Uccella S, La Rosa S, Volante M, Papotti M (2018) Immunohistochemical biomarkers of gastrointestinal, pancreatic, pulmonary, and thymic neuroendocrine neoplasms. Endocr Pathol 29:150-168
Wang J, Wei B, Albarracin CT, Hu J, Abraham SC, Wu Y (2014) Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology, and end results (SEER) database. BMC Cancer 14:147
Abou Dalle I, Abbas J, Boulos F, Salem Z, Assi HI (2017) Primary small cell carcinoma of the breast: a case report. J Med Case Rep 11:290
Tremelling A, Samuel S, Murray M (2017) Primary small cell neuroendocrine carcinoma of the breast—a case report and review of the literature. Int J Surg Case Rep 38:29-31
Alkaied H, Harris K, Brenner A, Awasum M, Varma S (2012) Does hormonal therapy have a therapeutic role in metastatic primary small cell neuroendocrine breast carcinoma? Case report and literature review. Clin Breast Cancer 12:226-230
Jesinghaus M, Konukiewitz B, Keller G, et al (2017) Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas. Mod. Pathol 30:610-619
Woischke C, Schaaf CW, Yang HM et al (2017) In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components. Mod Pathol 30: 95-103
Rakha EA, Reis-Filho JS, Sasano H, Wu Y (2019) Neuroendocrine tumor. In: WHO classification of tumours editorial board. Breast tumours. WHO classification of tumours series, 5th ed. IARC, Lyon, pp 156-158
Sapino A, Righi L, Cassoni P, Papotti M, Gugliotta P, Bussolati G (2001) Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol 14:768-776
Marchiò C, Geyer FC, Ng CKY, et al (2017) The genetic landscape of breast carcinomas with neuroendocrine differentiation. J Pathol 241:405–419
Terlević R, Perić Balja M, Tomas D, Skkenderi F, Kruslin B, Vranic S, Demirovic A (2019) Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer. Ann Diagn Pathol 38:62-66
Kumar U, Grigorakis SI, Watt HL, Sasi R, Snell L, Watson P, Chaudhari S (2005) Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1–5 and correlation with receptor protein expression and tumor pathology. Breast Cancer Res Treat 92:175–86
Frati A, Rouzier R, Lesieur B, Werkoff G, Antoine M, Rodenas A, Darai E, Chereau E (2014) Expression of somatostatin type-2 and -4 receptor and correlation with histological type in breast cancer. Anticancer Re 34:3997–4003
Mohanty SK, Kim SA, DeLair DF, Bose S, Laury AR, Shefali C, Mertens RB, Dhall D (2016) Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation. Mod Pathol 29:788-798
Papalampros A, Mpaili E, Moris D, Sarlanis H, Tsoli M, Felekouras E, Trafalis DT, Kontos M (2019) A case report on metastatic ileal neuroendocrine neoplasm to the breast masquerading as primary breast cancer: a diagnostic challenge and management dilemma. Medicine 98:e14989
La Rosa S, Casnedi S, Maragliano R, Goyault G, Weber JC, Louis B, Schlund E, Sessa F (2015) Breast metastasis as the first clinical manifestation of ileal neuroendocrine tumor. A challenging diagnosis with relevant clinical implications. Endocr Pathol 26:145–51
Uccella S, Mathias-Guiu X, La Rosa S (2020) Genitourinary neuroendocrine neoplasms. In: Asa SL, La Rosa S, Mete O (eds) The spectrum of neuroendocrine neoplasia. Practical approach to diagnosis, classification and therapy. New York, Springer, in press
Uccella S, La Rosa S (2020) Neuroendocrine neoplasms of the upper aerodigestive tract, ear and salivary glands. In: Asa SL, La Rosa S, Mete O (eds) The spectrum of neuroendocrine neoplasia. Practical approach to diagnosis, classification and therapy. New York, Springer, in press
Uccella S, Ottini G, Facco C, Maragliano R, Asioli S, Sessa F, La Rosa S (2017) Neuroendocrine neoplasms of the head and neck and olfactory neuroblastoma. Diagnosis and classification. Pathologica 109:14-30
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of Interest
The authors declare that they have no conflict of interest.
Ethics Approval
Not pertinent.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Uccella, S., Finzi, G., Sessa, F. et al. On the Endless Dilemma of Neuroendocrine Neoplasms of the Breast: a Journey Through Concepts and Entities. Endocr Pathol 31, 321–329 (2020). https://doi.org/10.1007/s12022-020-09637-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-020-09637-y